Neos Therapeutics Receives CRL from FDA for Cotempla XR-ODT By: Benzinga via Benzinga November 10, 2015 at 18:00 PM EST Neos Therapeutics, Inc. (Nasdaq: NEOS) today announced that the Company received a Complete Response Letter (CRL) from the U.S. Food and ... Read More >> Related Stocks: Neos Therapeutics